Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Brief
On November 9, 2024, a research team led by Professor Kim Sang-ryong at Kookmin University and colleagues published a study in Stem Cell Research & Therapy. The researchers found that human mesenchymal stem cells injected into mice with Spinocerebellar Ataxia Type 2 (SCA2) significantly improved motor function and prevented neurodegeneration, offering new hope for treating this incurable disease.
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
